The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

PURPOSE: The Prostate Health Index (phi) is a new test combining total, free and [-2]proPSA into a single score. It was recently approved by the FDA and is now commercially available in the U.S., Europe and Australia. We investigate whether phi improves specificity for detecting clinically significa...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Urol
Päätekijät: Loeb, Stacy, Sanda, Martin G., Broyles, Dennis L., Shin, Sanghyuk S., Bangma, Chris H., Wei, John T., Partin, Alan W., Klee, George G., Slawin, Kevin M., Marks, Leonard S., van Schaik, Ron H. N., Chan, Daniel W., Sokoll, Lori J., Cruz, Amabelle B., Mizrahi, Isaac A., Catalona, William J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404198/
https://ncbi.nlm.nih.gov/pubmed/25463993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.10.121
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia